Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. PAXLOVID (PF-07321332/ritonavir) - COVID-19
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

PAXLOVID (PF-07321332/ritonavir) - COVID-19

Medicine - Posted on Apr 25 2022
Active substance (DCI)
  • PF-07321332/Ritonavir
history (2)
  • Economic analysis
    4/6/22

    PAXLOVID (PF-07321332 / ritonavir) - Covid-19

    Key points Favourable opinion for reimbursement in the treatment of coronavirus disease 2019 (COVID-19) in adults who do not...
    CAV :
    54321
    icône flèche
  • 1/21/22

    PAXLOVID (PF-07321332/ritonavir) - COVID-19

    Concernant l'Autorisation d’accès précoce octroyée le 20 janvier 2022 à la spécialité PAXLOVID du laboratoire PFIZER dans l'...
    icône flèche
Technical information
ATC code
  • Non encore attribué
Manufacturer
PFIZER
Presentation

PAXLOVID 150 / 100 mg, comprimés pelliculés (PF-07321332/ritonavir)
B/30 comprimés pelliculés - (Code CIP : 34009 302 455 1 4)

All our publications
    COVID-19 Drug therapy Virus diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
10ZhmgLLT7HngkZA